Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Colombel

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
BJU International|August 4, 2020
Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer: a blinded prospective multicentric studyPaulo Gontero, Emanuele Montanari, Morgan Roupret, et al.
The Journal of Urology|April 22, 2020
Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Nonmuscle Invasive Bladder Cancer Followup: A Blinded, Prospective Cohort, Multicenter European StudyMorgan Roupret, Paolo Gontero, Stuart R C McCracken, et al.
Diagnostic and Interventional Imaging|June 22, 2023
Characterization of high-grade prostate cancer at multiparametric MRI using a radiomic-based computer-aided diagnosis system as standalone and second readerTristan Jaouen, Rémi Souchon, Paul C Moldovan, et al.
European Urology Focus|March 18, 2022
Reducing the Frequency of Follow-up Cystoscopy in Low-grade pTa Non-muscle-invasive Bladder Cancer Using the ADXBLADDER BiomarkerMorgan Rouprêt, Paolo Gontero, Stuart R C McCracken, et al.
European Urology|May 25, 2020
Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS"Marc-Oliver Grimm, Antoine G van der Heijden, Marc Colombel, et al.
Human Molecular Genetics|December 25, 2007
Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytomaGiuseppe Gasparre, Eric Hervouet, Elodie de Laplanche, et al.
The Lancet. Oncology|November 25, 2018
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic studyOlivier Rouvière, Philippe Puech, Raphaële Renard-Penna, et al.
Cancers|January 11, 2022
Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL)Anne-Sophie Belmont, Christophe Sajous, Amandine Bruyas, et al.
Health and Quality of Life Outcomes|May 12, 2017
International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancerMarieke van Leeuwen, Jacobien M Kieffer, Fabio Efficace, et al.
European Urology Open Science|October 12, 2023
Quality of Life in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS TrialChristine G J I van Straten, Christien Caris, Marc-Oliver Grimm, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
BJU International|August 4, 2020
Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer: a blinded prospective multicentric studyPaulo Gontero, Emanuele Montanari, Morgan Roupret, et al.
The Journal of Urology|April 22, 2020
Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Nonmuscle Invasive Bladder Cancer Followup: A Blinded, Prospective Cohort, Multicenter European StudyMorgan Roupret, Paolo Gontero, Stuart R C McCracken, et al.
Diagnostic and Interventional Imaging|June 22, 2023
Characterization of high-grade prostate cancer at multiparametric MRI using a radiomic-based computer-aided diagnosis system as standalone and second readerTristan Jaouen, Rémi Souchon, Paul C Moldovan, et al.
European Urology Focus|March 18, 2022
Reducing the Frequency of Follow-up Cystoscopy in Low-grade pTa Non-muscle-invasive Bladder Cancer Using the ADXBLADDER BiomarkerMorgan Rouprêt, Paolo Gontero, Stuart R C McCracken, et al.
European Urology|May 25, 2020
Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS"Marc-Oliver Grimm, Antoine G van der Heijden, Marc Colombel, et al.
Human Molecular Genetics|December 25, 2007
Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytomaGiuseppe Gasparre, Eric Hervouet, Elodie de Laplanche, et al.
The Lancet. Oncology|November 25, 2018
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic studyOlivier Rouvière, Philippe Puech, Raphaële Renard-Penna, et al.
Cancers|January 11, 2022
Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL)Anne-Sophie Belmont, Christophe Sajous, Amandine Bruyas, et al.
Health and Quality of Life Outcomes|May 12, 2017
International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancerMarieke van Leeuwen, Jacobien M Kieffer, Fabio Efficace, et al.
European Urology Open Science|October 12, 2023
Quality of Life in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS TrialChristine G J I van Straten, Christien Caris, Marc-Oliver Grimm, et al.
Pageof 12